Literature DB >> 832377

Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay.

A G Foti, H Herschman, J F Cooper.   

Abstract

We compared results of measurement of prostatic acid phosphatase activity in serum and various tissues by enzymatic assay and radioimmunoassay. By enzymatic assay, activity in serum is lost rapidly, even at room temperature. In contrast, there was no change in antigenic activity during 48 h by radioimmunoassay. The radioimmunoassay was more specific in 12 tissues and in serum than were several enzymatic assays that make use of inhibitors of the enzyme. The enzymatic assay resulted in 26.6% (24/90) false positives from non-prostatic cancer patients. In contrast, with radioimmunoassay there were only 5.5% (5/90) false positives. We conclude that immunological detection of prostatic acid phosphatase is the more reliable technique.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832377

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Pathology-Epitomes of Progress: Prostatic Acid Phosphatase (Male PAP).

Authors:  F M Finck
Journal:  West J Med       Date:  1980-04

2.  Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.

Authors:  Tsai-Der Chuang; Siu-Ju Chen; Fen-Fen Lin; Suresh Veeramani; Satyendra Kumar; Surinder K Batra; Yaping Tu; Ming-Fong Lin
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

3.  Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?

Authors:  Huan Xu; Fubo Wang; Huizhen Li; Jin Ji; Zhi Cao; Ji Lyu; Xiaolei Shi; Yasheng Zhu; Chao Zhang; Fei Guo; Ziyu Fang; Bo Yang; Yinghao Sun
Journal:  Dis Markers       Date:  2019-01-23       Impact factor: 3.434

Review 4.  Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.

Authors:  Prosper Kanyong; Sean Rawlinson; James Davis
Journal:  J Cancer       Date:  2016-02-10       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.